Anticoagulation

Sonika Malik, Anju Bhardwaj, Matthew Eisen, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Yugo Yamashita

Payam Pournazari, Su Min Chang, Stephen H Little, et al

Robert Barcelona

Read time: 23m

Karthiek R Narala, Thomas A LaLonde, Sohail Hassan, et al

Broadcast

Anticoagulation
Extended Thromboprophylaxis in Medically Ill Patients

Alex Spyropoulos, Gary E Raskob

Watch time: 1h 2m 6s

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Johny Nicolas, Usman Baber, Roxana Mehran

Harriette Van Spall, Stefan James

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Broadcast

Anticoagulation

Vascular Disease and Surgery
Radcliffe Premiere TV: ESC 2022

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Media

CRT 2020: Duration of DAPT treatment in ST prevention

Dean J Kereiakes

Watch time: 11m 55s
TCT Connect 2020: The XIENCE 90/28 Trials

Roxana Mehran

Watch time: 8m 43s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag,

Watch time: 17m 13s
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall

Watch time: 15m 2s

Federico M Asch, Jan Belohlavek, Rupert Bauersachs, et al

Watch time: 4h 24m 8s (20 videos)
USC 2021 Discussion: Optimal Antiplatelet Regimen in High Bleeding Risk

Mirvat Alasnag, Khaled Al-Shaibi, Roisin Colleran, et al

Watch time: 21m 10s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas

Watch time: 6m 33s
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao

Watch time: 8m 40s
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe

Watch time: 5m 43s
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas

Watch time: 9m

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 9s

Articles

Management of Venous Thromboembolism

Nazli Okumus

,

Ashley Park

,

Eugene Yuridistky

,

James M Horowitz

,

Michael A Solomon

,

Published:

27 November 2024

Citation:

US Cardiology Review 2024;18:e21.

DOI:

https://doi.org/10.15420/usc.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1761
  • Downloads: Downloads 140
  • Read time: 29m 12s

Prosthetic Aortic Valve Thrombosis

Payam Pournazari

,

Su Min Chang

,

Stephen H Little

,

Sachin Goel

,

Nadeen N Faza

,

Published:

08 July 2022

Citation:

US Cardiology Review 2022;16:e17.

DOI:

https://doi.org/10.15420/usc.2021.19
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4653
  • Downloads: Downloads 195
  • Citations: 1

Best Practices in Pharmacotherapy for Acute Coronary Syndromes

Robert Barcelona

,

Published:

01 July 2022

Citation:

US Cardiology Review 2022;16:e16.

DOI:

https://doi.org/10.15420/usc.2022.05
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4626
  • Downloads: Downloads 253
  • Read time: 23m

Dual Antiplatelet Regimens for TAVR and Cardiac CT Evaluation of Leaflets

Mirvat Alasnag

,

Waqar Ahmed

,

Ibrahim Al-Nasser

,

Khaled Al-Shaibi

,

Published:

10 February 2022

Citation:

US Cardiology Review 2022;16:e04.

DOI:

https://doi.org/10.15420/usc.2021.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1228
  • Downloads: Downloads 57
  • Read time: 15m